Accurate prediction of the drug-target affinity (DTA) in silico is of critical importance for modern drug discovery. Computational methods of DTA prediction, applied in the early stages of drug development, are able to speed it up and cut its cost significantly. A wide range of approaches based on machine learning were recently proposed for DTA assessment. The most promising of them are based on deep learning techniques and graph neural networks to encode molecular structures. The recent breakthrough in protein structure prediction made by AlphaFold made an unprecedented amount of proteins without experimentally defined structures accessible for computational DTA prediction. In this work, we propose a new deep learning DTA model 3DProtDTA, which utilises AlphaFold structure predictions in conjunction with the graph representation of proteins. The model is superior to its rivals on common benchmarking datasets and has potential for further improvement.

This study introduces the PocketCFDM generative diffusion model, aimed at improving the prediction of small molecule poses in the protein binding pockets. The model utilizes a novel data augmentation technique, involving the creation of numerous artificial binding pockets that mimic the statistical patterns of non-bond interactions found in actual protein–ligand complexes. An algorithmic method was developed to assess and replicate these interaction patterns in the artificial binding pockets built around small molecule conformers. It is shown that the integration of artificial binding pockets into the training process significantly enhanced the model's performance. Notably, PocketCFDM surpassed DiffDock in terms of non-bond interaction and steric clash numbers, and the inference speed. Future developments and optimizations of the model are discussed. The inference code and final model weights of PocketCFDM are accessible publicly via the GitHub repository: https://github.com/vtarasv/pocket-cfdm.git.

Classical protein-ligand docking has been a cornerstone technique in computational drug discovery for decades but has reached an accuracy and performance plateau. Recently introduced Machine Learning (ML)-based docking methods offer a promising paradigm shift, but their practical adoption is hampered by accuracy-to-speed trade-offs, inadequate benchmarking standards, and questionable chemical validity of predicted poses. In this study, we introduce ArtiDock─an ML-based docking technique optimized for high-throughput virtual screening applications. To evaluate ArtiDock, we developed a dedicated performance and accuracy benchmark for pocket-specific rigid protein-ligand docking, which mimics realistic industrial drug discovery scenarios and is based on the novel PLINDER data set. We demonstrate that ArtiDock is 29-38% more accurate in comparison to leading open-source and commercial classical docking techniques such as AutoDock, Vina, and Glide, while providing a low computational cost. ArtiDock notably excels in challenging docking scenarios involving unbound protein structures and binding sites containing ions and structured water molecules. Additionally, we demonstrated competitive accuracy of our approach at considerably higher throughput compared to a wide range of AI docking and AI cofolding methods using the PoseX benchmark. Our results show that ArtiDock could be considered as a method of choice in high-throughput virtual screening scenarios.

Classical protein-ligand docking has been a cornerstone technique in computational drug discovery for decades, but has reached an accuracy and performance plateau. Recently introduced Machine Learning (ML) based docking methods offer a promising paradigm shift, but their practical adoption is hampered by accuracy-to-speed trade-offs, inadequate benchmarking standards, and questionable chemical validity of predicted poses. In this study, we introduce ArtiDock - an ML-based docking technique optimized for high-throughput virtual screening applications. To evaluate ArtiDock, we developed a dedicated performance and accuracy benchmark for pocket-specific rigid protein-ligand docking, which mimics realistic industrial drug discovery scenarios and is based on the novel PLINDER dataset. We demonstrate that ArtiDock is 29-38% more accurate in comparison to leading open-source and commercial classical docking techniques such as AutoDock, Vina, and Glide, while providing a low computational cost. ArtiDock notably excels in challenging docking scenarios involving unbound protein structures and binding sites containing ions and structured water molecules. Our results show that ArtiDock could be considered as a method of choice in high-throughput virtual screening scenarios.